Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project

BACKGROUND: Despite advances in treatments, 30% to 50% of stage III‐IV head and neck squamous cell carcinoma (HNSCC) patients relapse within 2 years after treatment. The Big Data to Decide (BD2Decide) project aimed to build a database for prognostic prediction modeling. METHODS: Stage III‐IV HNSCC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalieri, Stefano, De Cecco, Loris, Brakenhoff, Ruud H., Serafini, Mara Serena, Canevari, Silvana, Rossi, Silvia, Lanfranco, Davide, Hoebers, Frank J. P., Wesseling, Frederik W. R., Keek, Simon, Scheckenbach, Kathrin, Mattavelli, Davide, Hoffmann, Thomas, López Pérez, Laura, Fico, Giuseppe, Bologna, Marco, Nauta, Irene, Leemans, C. René, Trama, Annalisa, Klausch, Thomas, Berkhof, Johannes Hans, Tountopoulos, Vasilis, Shefi, Ron, Mainardi, Luca, Mercalli, Franco, Poli, Tito, Licitra, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820974/
https://www.ncbi.nlm.nih.gov/pubmed/33107152
http://dx.doi.org/10.1002/hed.26515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820974/
https://www.ncbi.nlm.nih.gov/pubmed/33107152
http://dx.doi.org/10.1002/hed.26515

Ejemplares similares